ema retatrutide approval Want to learn more about the GLP-3 called retatrutide? Not yet FDA approved but soon. A weight loss game changer What Is Retatrutide for Weight
Description
Equal saline injections were administered for the sham group and OA group

[DOI] [PMC free article] [PubMed] [Google Scholar] 29.Davies M.J., Leiter L.A., Guerci B., Grunberger G., Ampudia-Blasco F.J., Yu C

Heppner, K

Your OB-GYN can discuss the specific risk-benefit analysis for your medical history
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted

1,2 Retatrutide trials have also flagged some concerns that arent typical for Wegovy
